191.82
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DHR?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$191.12
Offen:
$190.63
24-Stunden-Volumen:
1.43M
Relative Volume:
0.36
Marktkapitalisierung:
$135.75B
Einnahmen:
$24.57B
Nettoeinkommen (Verlust:
$3.60B
KGV:
37.98
EPS:
5.051
Netto-Cashflow:
$5.26B
1W Leistung:
+4.33%
1M Leistung:
-1.86%
6M Leistung:
-9.38%
1J Leistung:
+5.55%
Danaher Corp Stock (DHR) Company Profile
Firmenname
Danaher Corp
Sektor
Branche
Telefon
(202) 828-0850
Adresse
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DHR
Danaher Corp
|
191.82 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
TMO
Thermo Fisher Scientific Inc
|
484.81 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
|
IDXX
Idexx Laboratories Inc
|
575.96 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
115.16 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
303.62 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2025-03-14 | Hochstufung | Stifel | Hold → Buy |
| 2025-02-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-31 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Eingeleitet | HSBC Securities | Hold |
| 2023-12-13 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2023-12-07 | Herabstufung | Goldman | Buy → Neutral |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-01 | Eingeleitet | SVB Securities | Outperform |
| 2023-04-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-10-24 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-08-17 | Fortgesetzt | Bernstein | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-06-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Eingeleitet | Bernstein | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-10 | Bestätigt | BofA Securities | Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Buy |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-04-07 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-03 | Fortgesetzt | Barclays | Overweight |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Fortgesetzt | Stifel | Hold |
| 2019-10-28 | Bestätigt | Needham | Buy |
| 2019-10-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-07-19 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2019-02-25 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Needham | Buy |
| 2018-04-20 | Bestätigt | Stifel | Buy |
Alle ansehen
Danaher Corp Aktie (DHR) Neueste Nachrichten
Evercore Cuts Danaher (NYSE:DHR) Price Target to $225.00 - MarketBeat
Danaher: A Great Way To Play Healthcare For Long-Term Dividend Growth Investors (DHR) - Seeking Alpha
What to Expect From Danaher Corporation's Q1 2026 Earnings Report - Barchart
Rathbones Group PLC Has $60.78 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
Major Investors Accumulate Danaher Shares Amid Price Weakness - AD HOC NEWS
Danaher Corp. Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
Tritonpoint Wealth LLC Lowers Stake in Danaher Corporation $DHR - MarketBeat
Global Trust Asset Management LLC Grows Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (DHR) stock price, news, quote and history - Yahoo Finance UK
Danaher Corporation (DHR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Molecular Diagnostics Market Size is Expected to Reach USD 43.50 Billion by 2035 Owing to the Surging Demand for Accurate and Early Disease Detection Globally | SNS Insider - GlobeNewswire Inc.
Danaher Corporation $DHR Shares Bought by Aberdeen Group plc - MarketBeat
Triad Investment Management Purchases New Stake in Danaher Corporation $DHR - MarketBeat
Bank Pictet & Cie Europe AG Boosts Stock Position in Danaher Corporation $DHR - MarketBeat
DANAHER CORP CEDEAR EACH 54 REP (DHR.BA) stock price, news, quote and history - Yahoo Finance UK
Unisphere Establishment's Danaher Corp(DHR) Holding History - GuruFocus
Danaher Corporation (1DHR.MI) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Masimo (MASI) agrees to $180 cash takeover by Danaher; vote set May 1, 2026 - Stock Titan
Nisa Investment Advisors LLC Raises Stock Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Purchased by Capital Advisors Inc. OK - MarketBeat
Allspring Global Investments Holdings LLC Acquires 38,979 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corp. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
HT Partners LLC's Danaher Corp(DHR) Holding History - gurufocus.com
James Hambro & Partners LLP Sells 67,136 Shares of Danaher Corporation $DHR - MarketBeat
Northstar Advisory Group LLC Acquires New Shares in Danaher Corporation $DHR - MarketBeat
J. Safra Sarasin Holding AG Has $31.57 Million Stake in Danaher Corporation $DHR - MarketBeat
Mn Services Vermogensbeheer B.V. Acquires 5,736 Shares of Danaher Corporation $DHR - MarketBeat
DHR Stock Price, Quote & Chart | DANAHER CORP (NYSE:DHR) - ChartMill
Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Aug Gainers: Can Danaher Corporation beat the S P 5002026 Sector Review & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Danaher Corp. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Danaher Corporation $DHR Shares Sold by Cooper Investors PTY Ltd. - MarketBeat
Beacon Investment Advisory Services Inc. Lowers Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corp (MIL:1DHR) Bonds - GuruFocus
Promising Industrial Stocks To Follow TodayMarch 29th - MarketBeat
Best Biotech Stocks To Watch TodayMarch 29th - MarketBeat
Danaher Corp (MIL:1DHR) Stock Price & 30 Year Financial Data - GuruFocus
Biotech Stocks To Keep An Eye OnMarch 28th - MarketBeat
Waycross Partners LLC Buys 15,000 Shares of Danaher Corporation $DHR - MarketBeat
Masimo Corp Stock Faces Uncertainty Amid Analyst Downgrade and Pending Danaher Acquisition Deal - AD HOC NEWS
Danaher to Acquire Masimo Diagnostics in $9.9B Deal - usaherald.com
Danaher Corp. stock underperforms Friday when compared to competitors - MarketWatch
Danaher Corp. Stock: Business Model Strength and Key Investor Catalysts Ahead of Q1 2026 Earnings - AD HOC NEWS
Riverbridge Partners LLC Cuts Stock Holdings in Danaher Corporation $DHR - MarketBeat
Raymond James downgrades Masimo stock rating on Danaher deal - Investing.com
Vanguard (NYSE: DHR) disaggregates holdings, reports 0 shares for parent - Stock Titan
Danaher Corporation $DHR Shares Bought by Peak Financial Advisors LLC - MarketBeat
156,015 Shares in Danaher Corporation $DHR Acquired by Defender Capital LLC. - MarketBeat
Danaher Corp. stock faces pressure amid life sciences slowdown and market shifts - AD HOC NEWS
Is It Time To Reassess Danaher (DHR) After Recent Share Price Weakness? - simplywall.st
Finanzdaten der Danaher Corp-Aktie (DHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):